editorial | Q871232 |
scholarly article | Q13442814 |
P50 | author | Stephen Lawn | Q28151824 |
Robin Wood | Q60590121 | ||
P2860 | cites work | Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults | Q28472258 |
Rapid molecular detection of tuberculosis and rifampin resistance | Q29617127 | ||
Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings | Q33920318 | ||
Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults | Q33982474 | ||
Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study | Q34125176 | ||
Epidemiology of HIV-associated tuberculosis | Q34519940 | ||
Timing of initiation of antiretroviral drugs during tuberculosis therapy | Q34790184 | ||
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America | Q34974892 | ||
Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis | Q35121804 | ||
Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals | Q36141214 | ||
Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings | Q37168581 | ||
Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa | Q37179716 | ||
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial | Q37189075 | ||
Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections | Q37240766 | ||
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa | Q37265947 | ||
Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. | Q37357376 | ||
Immune reconstitution disease of the central nervous system. | Q37447778 | ||
The HIV-associated tuberculosis epidemic--when will we act? | Q37757652 | ||
Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa | Q38374183 | ||
Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis | Q39523752 | ||
Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources | Q42977188 | ||
Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study | Q46350540 | ||
Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy | Q80051726 | ||
Optimum time to initiate antiretroviral therapy in patients with HIV-associated tuberculosis: there may be more than one right answer | Q81382088 | ||
Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis | Q83161994 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | meningitis | Q48143 |
tuberculous meningitis | Q3854687 | ||
P304 | page(s) | 1384-1387 | |
P577 | publication date | 2011-06-01 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Poor prognosis of HIV-associated tuberculous meningitis regardless of the timing of antiretroviral therapy | |
P478 | volume | 52 |
Q38113260 | Drug-resistant tuberculous meningitis |
Q34212799 | Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the |
Q37965693 | Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy |
Q38414352 | Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review |
Q36058313 | Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis |
Q37285167 | Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa |
Search more.